CPH Pharma ApS: Financial statements 2025
CVR: 37110248
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
CPH Pharma ApS (CVR 37110248) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 4,432,157 and a net result of DKK 1,881,849 compared with DKK 1,257,143 the year before. That is an increase of 32.2% compared with the year before. Equity in the 2025 report amounted to DKK 3,102,300. The solvency ratio was 73.6%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 4,432,157
- Profit/Loss
- DKK 1,881,849
- Equity
- DKK 3,102,300
- Total Assets
- DKK 4,216,756
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 4.4 mio. | 1.9 mio. | 3.1 mio. | 4 |
| 2024 | - | 3.4 mio. | 1.3 mio. | 3.2 mio. | 3 |
| 2023 | - | 3 mio. | 1 mio. | 2 mio. | 3 |
| 2022 | - | 1.7 mio. | 587 t. | 1.3 mio. | 2 |
| 2021 | - | 1.6 mio. | 895 t. | 1 mio. | 1 |
Official annual report
How creditworthy is CPH Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
CPH Pharma ApS has published its annual report for 2024. Gross profit came to DKK 3,353,608, and the net result was DKK 1,257,143.
About CPH Pharma ApS
CPH Pharma ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2015. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Kamran Khasadar. The company is owned by Qi Holding APS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 4,432,157 and a net result of DKK 1,881,849 compared with DKK 1,257,143 the year before. Equity in the 2025 report amounted to DKK 3,102,300.